<DOC>
	<DOCNO>NCT00154076</DOCNO>
	<brief_summary>To assess efficacy safety Zonisamide Topiramate Initial Monotherapy Untreated Epilepsies</brief_summary>
	<brief_title>A Multicenter Comparative Trial Zonisamide Topiramate Initial Monotherapy Untreated Epilepsies</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients 13 year old ( complete elementary school course ) . 2 . Patients least two seizure past least one seizure last 3 month screen . 3 . Patients antiepileptic drug last 4 month . 4 . Women childbearing age agree contraception participate clinical trial . Exclusion criterion : 1 . Pregnancy 2 . Patients progressive neurologic disease 3 . Allergy sulfonamides 4 . Use acetazolamide within year 5 . Hemolytic anemia 6 . Patients abnormal liver function ( GOT GPT ) value twice normal value . 7 . Patients abnormal renal function ( BUN Creatinine ) value three time normal value . 8 . Patients history drug alcohol abuse . 9 . Glucose6phosphate dehydrogenase deficiency . 10 . Patients detect renal stone KUB ( KidneyUreterBladder ) test . 11 . Patients progressive internal surgical disease . 12 . Patients progressive psychiatric disease . 13 . Patients mental retardation ( IQ 70 less ) . 14 . Patients take Vit C .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>